Abstract:Background Puerarin (Pue) is an isoflavone compound with significant therapeutic effect on cardiovascular diseases, but its poor water solubility and low oral bioavailability limit clinical application. Methods In this study, Pue was prepared into PLGA nanoparticles (Pue-PLGA NPs) by emulsion solvent volatilization method. The morphology, particle size, Zeta potential, X-ray diffraction (XRD), and fourier transform infrared (FTIR) of the NPs were characterized. Additionally, their stability and in vitro release were evaluated. SD rats were orally administered wtih Pue and Pue-PLGA NPs, and a high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was established to determine the concentration of blood samples and to investigate the pharmacokinetic behaviour of Pue and Pue-PLGA NPs in rats. Results The NPs were observed by transmission electron microscopy (TEM) as regular spheroids and uniformly dispersed. The average particle size of the NPs was (167.1±5.26）nm, the Zeta potential was (-29.88±2.46)mV, the encapsulation rate was (83.12 %±4.73 %) and the drug loading capacity was (7.75 %±1.81 %). The results of in vitro release showed that the drug was released slowly and continuously from the NPs, reaching the release platform in 24 h, and the cumulative release amount was (88.55±2.86) %. The pharmacokinetic results showed that the AUC0–24, AUC0-∞, Cmax, Tmax, t1/2, MRT0–24 and MRT0-∞ of Pue-PLGA NPs were 2.196, 1.978, 1.327, 1.5, 1.385, 3.915 and 3.140 times of Pue, respectively. The relative bioavailability was (197.82±25.28) %. Conclusion These results indicated that the prepared nanoparticles had small particle size, high encapsulation rate, drug loading capacity and good slow-release effect, and could significantly improve the oral bioavailability of Pue in rats.

Preparation and in Vitro Release Evaluation of Puerarin Sustained-Release Tablet

Study on pramipexole dihydrochloride sustained-release tablets

Preparation of Zhitong Sustained-Release Tablet and Its Release Property in Vitro

Improvement in Solubility and Bioavailability of Puerarin by Mechanochemical Preparation

[Formulation Optimization and Drug Release in Vitro of Membrane Controlled Tablets of Puerarin Inclusion Compound].

Preparation and in vitro evaluation of gastroretentive dosage form containing puerarin-HP-β-CD inclusion complex

Preparation and Release Rate in Vitro of Puerarin Enteric Nanoparticles

Study on the Formulation Optimization and Drug Release in Vitro of Two-Layer Controlled Osmotic-Pump Tablets of Puerarin

Study on Preparation of Puerarin Proliposomes and Its Pharmaceutical Characteristics in Vitro

Preparation and Evaluation of Puerarin-loaded PLGA Nanoparticles for Improving Oral Bioavailability in SD Rats

Optimization of pramipexole hydrochloride sustained-release tablets using Box-Behnken design and mechanism of in vitro drug release

Preparation and in Vitro Release Study of Paeonol Gastric Adhesive Tablets

Preparation of Compound Pseudoephedrine Hydrochloride Sustained-Release Inlay Tablets and Its Release in Vitro

Preparation and in Vitro Release of Garcinia Glycosides Sustained-Release Tablets

Preparation and optimization of sustained-release tablets of propafenone hydrochloride β-CD inclusion complex

[Study on Sustained Release Preparations of Epimedium Component].

Preparation and release behavior of Curcumin Sustained Tablets

Preparation and in Vitro Drug Release of Paracetamol and Tramadol Hydrochloride Substained Release Tablets

[Preparation and in Vitro Release of Ginkgo Biloba Extract Sustained-Release Tablets].

Preparation of Sustained-Release Tetramethylpyrazine Phosphate Tablet and its Bioavailability on Rabbits

Preparation of Liposomes Encapsulating Puerarin-Cyclodextrin Complexes and Its Pharmaceutical Characteristics in Vitro